The Better Meat Co. Becomes BMC Ingredients, Chasing Whey's Crown
A decade-old alt-meat innovator is repositioning as a B2B whole-food protein supplier, wagering that its mycelium ingredient can undercut record-high whey prices without sacrificing the "clean label" appeal manufacturers now demand.
From Alt-Meat Innovator to Ingredient Supplier
Sacramento-based The Better Meat Co. has changed its trade name to BMC Ingredients, a move the company frames not as a pivot away from its roots but as a widening of its ambitions. For years, the firm built its reputation supplying mycelium-based ingredients to plant-based and blended meat manufacturers. The new name signals a deliberate shift toward a much larger addressable market: functional protein ingredients for the entire food and beverage industry, from sports nutrition to bakery.
The company's legal entity remains unchanged, but its commercial identity now centers on two flagship formats of its proprietary Rhiza mycelium ingredient. Rhiza Tex is engineered for texture-critical applications such as meat analogues and hybrid meat blends, while Rhiza Pro targets solubility- and emulsification-dependent formats — smoothies, protein bars, baked goods, and pasta.
Key Takeaways
- The Better Meat Co. rebrands as BMC Ingredients, expanding Rhiza mycelium beyond alt-meat into mainstream protein applications.
- The pitch: a whole-food, minimally processed alternative to increasingly expensive whey and other protein isolates.
- A commercial-scale facility is commissioned for Q2 2027, targeting roughly 100 dry metric tonnes of output monthly — the company's existing Sacramento site is already sold out through year-end.
- Whey protein concentrate and isolate costs have climbed 40–139% over the past two years amid a structural dairy-processing shortage.
- For MENA food and sports-nutrition manufacturers, the shift adds a new formulation option at a moment when whey-dependent supply chains are under sustained cost pressure.
Positioning Against a Whey Market in Crisis
The timing is not incidental. Whey protein concentrate and isolate — long the default protein source for supplements, bars, and fortified foods — are in the midst of a supply squeeze that industry trackers describe as structural rather than cyclical. Whey supply is tethered to cheese production volumes and constrained further by limited filtration and drying capacity, and manufacturers have sold forward contracts well into the year, leaving little spot-market inventory for new buyers.
Commodity data from the sector shows standard whey protein concentrate pricing has more than doubled since 2023, with some finished protein products up 50–110% year-over-year. That cost pressure is forcing supplement and functional-food brands to explore blended formulations and alternative protein sources, even when whey's bioavailability remains difficult to match — creating an opening for whole-food ingredients like Rhiza to compete less as a niche alt-protein and more as a direct commercial substitute.
"-As food companies look for scalable, all-natural alternatives to increasingly expensive protein isolates, we're excited to offer a whole-food mycelium ingredient that delivers nutrition, functionality, and versatility across categories."
The Science: Whole Biomass, Not an Isolate
Rhiza is produced through fermentation of the fungal strain Neurospora crassa, a species with a long history of traditional food use — most notably in oncom, a fermented Indonesian staple, and in the ripening cultures used for Roquefort cheese. Unlike protein isolates, which strip away fiber and other whole-food components through fractionation, Rhiza retains its biomass structure, delivering protein and fibre alongside a naturally nutrient-dense profile that the company says compares favourably to oats for fibre content and bananas for potassium, with no cholesterol and minimal saturated fat.
That whole-food framing is central to the rebrand. Rather than competing on the "alternative protein" narrative that has struggled commercially in recent years, BMC Ingredients is positioning Rhiza against processed protein isolates broadly — arguing that avoiding heavy fractionation is itself the differentiator, not the fungal origin.
The business has built a strong position in an attractive, resilient category where clean-label, minimally processed ingredients are increasingly valued over conventional isolates.
Editorial synthesis of company positioning — BMC IngredientsA Sector-Wide Retreat from "Alt-Meat," Toward Ingredients
BMC Ingredients' repositioning mirrors a broader retreat across the plant-based sector, where the alternative-meat category has cooled considerably after its early-2020s boom. Beyond Meat itself rebranded earlier this year as Beyond The Plant Protein Co., pursuing entry into higher-margin protein-drink and ingredient segments. The pattern suggests plant- and fungi-based protein technology developed for meat analogues is finding a more durable commercial home as a B2B functional ingredient supplied into categories with structurally strong demand — sports nutrition, bakery, and fortified snacking — rather than as a stand-alone consumer meat substitute.
The company's existing Sacramento demonstration plant is reportedly at capacity, with purchase orders already exceeding what it can fulfil through the rest of the year; several larger orders have had to be turned away for lack of production volume. The Q2 2027 commercial facility, once operational, is intended to relieve that bottleneck and support global commercialisation of Rhiza at scale.
Relevance for Saudi Arabia and the MENA Region
For Saudi and Gulf food manufacturers, the emergence of a whole-food mycelium alternative to whey arrives at a relevant moment. Sports nutrition, high-protein snacking, and functional bakery are among the fastest-growing categories in the Kingdom's consumer market, and most rely on imported whey and protein isolates whose costs are now rising sharply in source markets, a pressure that inevitably flows through regional supply chains.
A scalable, minimally processed protein ingredient could offer regional manufacturers a hedge against whey volatility while supporting clean-label positioning increasingly demanded by health-conscious Gulf consumers. It also aligns with Vision 2030's push toward diversified, resilient food manufacturing inputs — though actual uptake will depend on regulatory approval pathways for novel fermentation-derived ingredients in Saudi Arabia and the wider GCC, as well as competitive pricing once the new facility is operational.
Editorial View
BMC Ingredients' rebrand is a useful data point on where fermentation-derived protein technology is finding commercial traction: not in convincing consumers to eat "fake meat," but in quietly displacing processed protein isolates inside products consumers already buy. The wager is straightforward — whey's supply constraints are structural, not seasonal, and any credible whole-food alternative that can scale stands to benefit regardless of how the broader alt-protein narrative fares.
Whether Rhiza can compete on cost and functionality at 100 tonnes a month remains to be tested commercially. But for MENA manufacturers watching whey costs climb with no near-term relief in sight, the emergence of credible, GRAS-cleared alternatives is worth tracking closely as formulation strategies evolve through 2027.
